The biotech drug developer posted revenue of $191.6 million in the period, also topping Street forecasts. Five analysts surveyed by Zacks expected ...
News
- FibroGen: 2Q Earnings Snapshot
- Pfenex: 2Q Earnings Snapshot
The biotechnology company posted revenue of $2.8 million in the period. Pfenex shares have climbed 96% since the beginning of the year. In the final ...
- What's Propelling Syros Pharmaceuticals Inc (NASDAQ:SYRS) After Lower Shorts Reported?
... “Syros Announces New Preclinical Data on SY-1365 at San Antonio Breast ... Yahoo.com published: “The Week Ahead In Biotech: Pending Clinical ...
- Is Selling Unum Therapeutics Inc. (UMRX) Here a Winning Strategy?
... Tumors at the San Antonio Breast Cancer Symposium – GlobeNewswire” published on November 09, 2018, Globenewswire.com published: “Unum ...
- What You Need to Know About Cannabis Incubators
... the well-known cannabis investor network Arcview Group, and has incubated more than 100 companies, including Wurk, Front Range Biosciences, ...